Antibiotic Resistance
Dilara Yıldırım and others
Tuberculosis (TB) is a common disease with high mortality and morbidity worldwide. Globally, an estimated 10.6 million people (95% uncertainty interval [UI]=9.9-11.4 million) developed TB in 2022, compared with 10.3 million in 2021 and 10.0 million in 2020. TB caused an estimated 1.30 million deaths worldwide in 2022 (95% UI=1.18-1.43 million). This was […] Read More
Abdurrahman Kaya and others
Aspergillus spp. are ubiquitous and frequently inhaled by humans as spores in the natural environment and hospital settings. Despite this high frequency of exposure, aspergillosis is a rare disease in humans. Many Aspergillus spp. have been defined as causing infections, including Aspergillus fumigatus and Aspergillus flavus, among the most common [...] Read More
Pınar Korkmaz and others
Antimicrobial resistance can lead to morbidity and mortality in serious infections. Therefore, antimicrobial resistance has been accepted as a global public health problem in the 21st century. Unnecessary and excessive use of drugs is a serious problem in our country as well as in the rest of the world. Unnecessarily used drugs play an important role (...) Read More
Yusuf Emre Özdemir and others
Burkholderia cepacia complex is aerobic, non-fermentative, multi-drug resistant Gram-negative bacilli containing 24 opportunistic pathogenic species (1). B. cepacia complex members are commonly found in natural environments because they easily adapt to harsh environments due to their genotypic and phenotypic plasticity and ability to mutate rapidly. B. cepacia complex can also grow substantially and survive in water-based (...) Read More